Hepatic iron overload does not prevent a sustained virological response to interferon-α therapy: A long term follow-up study in hepatitis C-infected patients with β thalassemia major

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 982-987

  Sievert, William ^a   Pianko, Stephen ^a   Warner, Sherryne ^a   Bowden, Scott ^b   Simpson, Ian ^a   Bowden, Don ^a   Locarnini, Stephen ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FERRITIN BLOOD LEVEL; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CELL DAMAGE; LIVER LEVEL; LONG TERM CARE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS GENE; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; BETA-THALASSEMIA; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; IRON; IRON OVERLOAD; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036117799     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04112-0     Document Type: Article

References (19)

1. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major
2. Hepatic iron concentration and total body iron stores in thalassemia major
3. Factors predictive of a beneficial response to therapy of hepatitis C
4. Response to interferon α therapy is influenced by the iron content of the liver
5. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C
6. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron
7. Histological grading and staging of chronic hepatitis
8. Measurement of iron in liver biopsies - A comparison of three analytical methods
9. Does iron concentration in a liver needle biopsy accurately reflect hepatic iron concentration in β-thalassemia?
10. Hepatitis C virus genotypes in Australia
11. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion dependent patients with thalassemia major and chronic hepatitis C
12. Long term efficacy of α interferon in β-thalassemics with chronic hepatitis C
13. Iron and chronic viral hepatitis
14. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
15. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
16. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial
17. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy
18. Efficacy of desferoxamine in preventing complications of iron overload in patients with thalassemia major
19. Survival in medically treated patients with homozygous beta-thalassemia